Email Email Print Print
Clip Clip & File

Only on :: Latest News

December 11, 2013

Bio-based butadiene joint development agreement between Braskem and Genomatica

Scott Jenkins

Braskem America (Philadelphia, Pa.; and Genomatica (San Diego, Calif.; announced an agreement for the joint development of a commercial process technology to make bio-based butadiene from renewable feedstocks. Braskem is the world’s leading producer of biopolymers and the world’s third largest producer of butadiene.
Under the agreement, Braskem anticipates providing significant funding of Genomatica’s development work over several years; will allocate significant Braskem R&D resources; and fund the construction and operation of pilot and demonstration-scale butadiene production plants using the process. In return, Braskem will receive certain exclusive license rights to use the resulting process technology in the Americas. Genomatica will also receive fees and royalties for each licensed commercial plant.
“Braskem has a clear strategy for investing in the research and development of renewable based chemical technologies as alternatives to complement our current product portfolio based on petrochemicals. In 2012, we became the world leader in Biopolymers when we announced the production of plastic made from sugarcane, and we are now further reinforcing this vision," said Alexandre Elias, director of renewable chemicals at Braskem.
“Our partnership brings the industry closer to commercializing a more sustainable and cost-predictable butadiene,” said Christophe Schilling, Ph.D., CEO of Genomatica.
The new agreement adds significantly to Genomatica’s butadiene program, which now includes investments of over $100 million anticipated under current agreements. Program milestones already include the successful production of pounds of butadiene in 2011, and funding from Versalis for Genomatica’s development efforts announced in April 2013.
The combined strength of current and future program partners will facilitate aggressive pursuit and delivery of commercial-grade process technologies for licensing to and use by the global chemical industry, using a range of feedstocks. The agreements with Braskem and Versalis provide a commercialization path in all major butadiene-producing and consuming regions of the world.
Butadiene, with a worldwide market demand of over 20 billion pounds per year, is a raw material used in the production of rubber for tires, electrical appliances, footwear, plastics, asphalt modifiers, additives for lubricating oil, pipes, building components, and latex.
The supply of butadiene, an important ‘C4’ chemical, has been decreasing due to a long-term shift to natural gas at petrochemical ‘cracking’ plants, and a scarcity of dedicated, ‘on-purpose’ production processes and facilities. This has resulted in substantial pricing volatility, which in turn impacts butadiene-based products, including tires. The butadiene process being developed by Genomatica and Braskem is expected to provide an economically competitive and environmentally-friendlier alternative, while providing a strategic alternative to the use of petroleum-based feedstocks.

Add a Comment


Please enter the letters or numbers you see in the image. (refresh)

Related Stories

LinkedIn Groups

Our LinkedIn group is now over 33,000 members strong!

  1. Join other CPI professionals from all over the globe and share best practices, expertise, concerns and more.
  2. Provide feedback to Chemical Engineering Editors

Current members represent Worley Parsons, DuPont, SABIC, Fluor, Air Products, LyondellBasell, Nalco, Dow Chemical, Dow Corning, BASF, Jacobs Engineering, ExxonMobil, Shell, Chevron and more.

Join Now

We also offer the following subgroup for more targeted discussions:

Search the Buyers' Guide

Plant Cost Index

Facts at Your Fingertips (archive)

Ask the Experts

Back Issues
To access this area, please log in or create an account.
Forgot your password?
Request it now.
Live chat by BoldChat